Plasma concentrations of endocannabinoids and related primary fatty acid amides in patients with post-traumatic stress disorder.

<h4>Background</h4>Endocannabinoids (ECs) and related N-acyl-ethanolamides (NAEs) play important roles in stress response regulation, anxiety and traumatic memories. In view of the evidence that circulating EC levels are elevated under acute mild stressful conditions in humans, we hypoth...

Full description

Bibliographic Details
Main Authors: Daniela Hauer, Gustav Schelling, Hannah Gola, Patrizia Campolongo, Julia Morath, Benno Roozendaal, Gilava Hamuni, Alexander Karabatsiakis, Piray Atsak, Michael Vogeser, Iris-Tatjana Kolassa
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23667516/?tool=EBI
id doaj-4ba9869d8b5847e4bc8c9d438436d256
record_format Article
spelling doaj-4ba9869d8b5847e4bc8c9d438436d2562021-03-03T23:23:33ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0185e6274110.1371/journal.pone.0062741Plasma concentrations of endocannabinoids and related primary fatty acid amides in patients with post-traumatic stress disorder.Daniela HauerGustav SchellingHannah GolaPatrizia CampolongoJulia MorathBenno RoozendaalGilava HamuniAlexander KarabatsiakisPiray AtsakMichael VogeserIris-Tatjana Kolassa<h4>Background</h4>Endocannabinoids (ECs) and related N-acyl-ethanolamides (NAEs) play important roles in stress response regulation, anxiety and traumatic memories. In view of the evidence that circulating EC levels are elevated under acute mild stressful conditions in humans, we hypothesized that individuals with traumatic stress exposure and post-traumatic stress disorder (PTSD), an anxiety disorder characterized by the inappropriate persistence and uncontrolled retrieval of traumatic memories, show measurable alterations in plasma EC and NAE concentrations.<h4>Methods</h4>We determined plasma concentrations of the ECs anandamide (ANA) and 2-arachidonoylglycerol (2-AG) and the NAEs palmitoylethanolamide (PEA), oleoylethanolamide (OEA), stearoylethanolamine (SEA), and N-oleoyldopamine (OLDA) by HPLC-MS-MS in patients with PTSD (n = 10), trauma-exposed individuals without evidence of PTSD (n = 9) and in healthy control subjects (n = 29). PTSD was diagnosed according to DSM-IV criteria by administering the Clinician Administered PTSD Scale (CAPS), which also assesses traumatic events.<h4>Results</h4>Individuals with PTSD showed significantly higher plasma concentrations of ANA (0.48 ± 0.11 vs. 0.36 ± 0.14 ng/ml, p = 0.01), 2-AG (8.93 ± 3.20 vs. 6.26±2.10 ng/ml, p<0.01), OEA (5.90 ± 2.10 vs. 3.88 ± 1.85 ng/ml, p<0.01), SEA (2.70 ± 3.37 vs. 0.83 ± 0.47, ng/ml, p<0.05) and significantly lower plasma levels of OLDA (0.12 ± 0.05 vs. 0.45 ± 0.59 ng/ml, p<0.05) than healthy controls. Moreover, PTSD patients had higher 2-AG plasma levels (8.93 ± 3.20 vs. 6.01 ± 1.32 ng/ml, p = 0.03) and also higher plasma concentrations of PEA (4.06 ± 1.87 vs. 2.63±1.34 ng/ml, p<0.05) than trauma-exposed individuals without evidence of PTSD. CAPS scores in trauma-exposed individuals with and without PTSD (n = 19) correlated positively with PEA (r = 0.55, p = 0.02) and negatively with OLDA plasma levels (r = -0.68, p<0.01). CAPS subscores for intrusions (r = -0.65, p<0.01), avoidance (r = -0.60, p<0.01) and hyperarousal (r = -0.66, p<0.01) were all negatively related to OLDA plasma concentrations.<h4>Conclusions</h4>PTSD appears to be associated with changes in plasma EC/NAE concentrations. This may have pathophysiological and diagnostic consequences but will need to be reproduced in larger cohorts.https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23667516/?tool=EBI
collection DOAJ
language English
format Article
sources DOAJ
author Daniela Hauer
Gustav Schelling
Hannah Gola
Patrizia Campolongo
Julia Morath
Benno Roozendaal
Gilava Hamuni
Alexander Karabatsiakis
Piray Atsak
Michael Vogeser
Iris-Tatjana Kolassa
spellingShingle Daniela Hauer
Gustav Schelling
Hannah Gola
Patrizia Campolongo
Julia Morath
Benno Roozendaal
Gilava Hamuni
Alexander Karabatsiakis
Piray Atsak
Michael Vogeser
Iris-Tatjana Kolassa
Plasma concentrations of endocannabinoids and related primary fatty acid amides in patients with post-traumatic stress disorder.
PLoS ONE
author_facet Daniela Hauer
Gustav Schelling
Hannah Gola
Patrizia Campolongo
Julia Morath
Benno Roozendaal
Gilava Hamuni
Alexander Karabatsiakis
Piray Atsak
Michael Vogeser
Iris-Tatjana Kolassa
author_sort Daniela Hauer
title Plasma concentrations of endocannabinoids and related primary fatty acid amides in patients with post-traumatic stress disorder.
title_short Plasma concentrations of endocannabinoids and related primary fatty acid amides in patients with post-traumatic stress disorder.
title_full Plasma concentrations of endocannabinoids and related primary fatty acid amides in patients with post-traumatic stress disorder.
title_fullStr Plasma concentrations of endocannabinoids and related primary fatty acid amides in patients with post-traumatic stress disorder.
title_full_unstemmed Plasma concentrations of endocannabinoids and related primary fatty acid amides in patients with post-traumatic stress disorder.
title_sort plasma concentrations of endocannabinoids and related primary fatty acid amides in patients with post-traumatic stress disorder.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2013-01-01
description <h4>Background</h4>Endocannabinoids (ECs) and related N-acyl-ethanolamides (NAEs) play important roles in stress response regulation, anxiety and traumatic memories. In view of the evidence that circulating EC levels are elevated under acute mild stressful conditions in humans, we hypothesized that individuals with traumatic stress exposure and post-traumatic stress disorder (PTSD), an anxiety disorder characterized by the inappropriate persistence and uncontrolled retrieval of traumatic memories, show measurable alterations in plasma EC and NAE concentrations.<h4>Methods</h4>We determined plasma concentrations of the ECs anandamide (ANA) and 2-arachidonoylglycerol (2-AG) and the NAEs palmitoylethanolamide (PEA), oleoylethanolamide (OEA), stearoylethanolamine (SEA), and N-oleoyldopamine (OLDA) by HPLC-MS-MS in patients with PTSD (n = 10), trauma-exposed individuals without evidence of PTSD (n = 9) and in healthy control subjects (n = 29). PTSD was diagnosed according to DSM-IV criteria by administering the Clinician Administered PTSD Scale (CAPS), which also assesses traumatic events.<h4>Results</h4>Individuals with PTSD showed significantly higher plasma concentrations of ANA (0.48 ± 0.11 vs. 0.36 ± 0.14 ng/ml, p = 0.01), 2-AG (8.93 ± 3.20 vs. 6.26±2.10 ng/ml, p<0.01), OEA (5.90 ± 2.10 vs. 3.88 ± 1.85 ng/ml, p<0.01), SEA (2.70 ± 3.37 vs. 0.83 ± 0.47, ng/ml, p<0.05) and significantly lower plasma levels of OLDA (0.12 ± 0.05 vs. 0.45 ± 0.59 ng/ml, p<0.05) than healthy controls. Moreover, PTSD patients had higher 2-AG plasma levels (8.93 ± 3.20 vs. 6.01 ± 1.32 ng/ml, p = 0.03) and also higher plasma concentrations of PEA (4.06 ± 1.87 vs. 2.63±1.34 ng/ml, p<0.05) than trauma-exposed individuals without evidence of PTSD. CAPS scores in trauma-exposed individuals with and without PTSD (n = 19) correlated positively with PEA (r = 0.55, p = 0.02) and negatively with OLDA plasma levels (r = -0.68, p<0.01). CAPS subscores for intrusions (r = -0.65, p<0.01), avoidance (r = -0.60, p<0.01) and hyperarousal (r = -0.66, p<0.01) were all negatively related to OLDA plasma concentrations.<h4>Conclusions</h4>PTSD appears to be associated with changes in plasma EC/NAE concentrations. This may have pathophysiological and diagnostic consequences but will need to be reproduced in larger cohorts.
url https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23667516/?tool=EBI
work_keys_str_mv AT danielahauer plasmaconcentrationsofendocannabinoidsandrelatedprimaryfattyacidamidesinpatientswithposttraumaticstressdisorder
AT gustavschelling plasmaconcentrationsofendocannabinoidsandrelatedprimaryfattyacidamidesinpatientswithposttraumaticstressdisorder
AT hannahgola plasmaconcentrationsofendocannabinoidsandrelatedprimaryfattyacidamidesinpatientswithposttraumaticstressdisorder
AT patriziacampolongo plasmaconcentrationsofendocannabinoidsandrelatedprimaryfattyacidamidesinpatientswithposttraumaticstressdisorder
AT juliamorath plasmaconcentrationsofendocannabinoidsandrelatedprimaryfattyacidamidesinpatientswithposttraumaticstressdisorder
AT bennoroozendaal plasmaconcentrationsofendocannabinoidsandrelatedprimaryfattyacidamidesinpatientswithposttraumaticstressdisorder
AT gilavahamuni plasmaconcentrationsofendocannabinoidsandrelatedprimaryfattyacidamidesinpatientswithposttraumaticstressdisorder
AT alexanderkarabatsiakis plasmaconcentrationsofendocannabinoidsandrelatedprimaryfattyacidamidesinpatientswithposttraumaticstressdisorder
AT pirayatsak plasmaconcentrationsofendocannabinoidsandrelatedprimaryfattyacidamidesinpatientswithposttraumaticstressdisorder
AT michaelvogeser plasmaconcentrationsofendocannabinoidsandrelatedprimaryfattyacidamidesinpatientswithposttraumaticstressdisorder
AT iristatjanakolassa plasmaconcentrationsofendocannabinoidsandrelatedprimaryfattyacidamidesinpatientswithposttraumaticstressdisorder
_version_ 1714811637574139904